Issue 14 The Blood Brain Barrier Baffles Big Pharma Despite there being a large unmet need for treatments in neurological disorders, big pharma is beginning to withdraw from drug development due to the challenge of crossing the blood-brain barrier,
Issue 12 Crossing the Blood Brain Barrier Over a century ago, Paul Ehrlich injected blue dye into the bloodstream of mice to view their biological structures. After dissecting the mice, he was surprised to find that all
